Roundhill Investments - GLP-1 & Weight Loss ETF
Limited financial coverage for OZEM.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Roundhill considers weight loss medications, particularly GLP-1 agonists, to be among the most groundbreaking innovations currently reshaping the global pharmaceutical landscape. This conviction underpins the Roundhill GLP-1 & Weight Loss ETF (OZEM), which is distinguished as the world's inaugural ETF exclusively focused on the GLP-1 and broader weight management sector. Notably, OZEM employs an active management approach.
- IPO
- 2024
- HQ
- New York, NY, US
Get TickerSpark's AI analysis on OZEM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $38.04M
- Div Yield
- 1.41%
- 52W High
- $37.15
- 52W Low
- $27.34
- 50D MA
- $32.21
- 200D MA
- $32.58
- Beta
- 0.47
- RSI (14)
- 33
- Avg Volume
- 16.35K
No earnings-call transcripts are available for OZEM yet.
- Free Float
- 0.0%
- Shares Outstanding
- 1.29M
- Float Shares
- 0
of shares held by institutions
25 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Susquehanna International Group, Llp | 43.47K | ▲ 9.54K |
| Cox Capital Mgt LLC | 40.39K | ▲ 40.39K |
| Commonwealth Equity Services, LLC | 36.67K | ▲ 756 |
| Oak Family Advisors, LLC | 29.89K | ▲ 1.75K |
| Perigon Wealth Management, LLC | 25.27K | ▲ 25.27K |
| Principal Securities, Inc. | 25.22K | ▲ 7.35K |
| Envestnet Asset Management Inc | 23.42K | ▲ 5.02K |
| Summit Financial, LLC | 17.59K | ▲ 17.59K |
| Advisor Group Holdings, Inc. | 14.58K | ▼ 194 |
| Ubs Group AG | 12.06K | ▲ 2.92K |
| Arrowroot Family Office, LLC | 10.71K | ▼ 28.34K |
| Lodestar Private Asset Management LLC | 10.53K | 0 |
Our OZEM coverage
Recent articles, reports, and earnings notes.
No research on OZEM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OZEM report →Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win
zacks.com · Oct 1
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Shares Down 0.4% – Time to Sell?
defenseworld.net · Aug 12
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
zacks.com · Jul 1
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
etftrends.com · Jun 11
Inside the GLP-1 Boom: ETF Picks for the Obesity Drug Market
zacks.com · Jun 10
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain
zacks.com · May 19
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 345.5% in April
defenseworld.net · Apr 27
3 Ways to Invest in the Growing GLP-1 Weight Loss Market
marketbeat.com · Apr 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.